Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Heme, a major functional form of iron in the cell, is synthesized in the mitochondria by ferrochelatase inserting ferrous iron into protoporphyrin IX. Heme deficiency was induced with N -methylprotoporphyrin IX, a selective inhibitor of ferrochelatase, in two human brain cell lines, SHSY5Y (neuroblastoma) and U373 (astrocytoma), as well as in rat primary hippocampal neurons. Heme deficiency in brain cells decreases mitochondrial complex IV, activates nitric oxide synthase, alters amyloid precursor protein, and corrupts iron and zinc homeostasis. The metabolic consequences resulting from heme deficiency seem similar to dysfunctional neurons in patients with Alzheimer's disease. Heme-deficient SHSY5Y or U373 cells die when induced to differentiate or to proliferate, respectively. The role of heme in these observations could result from its interaction with heme regulatory motifs in specific proteins or secondary to the compromised mitochondria. Common causes of heme deficiency include aging, deficiency of iron and vitamin B6, and exposure to toxic metals such as aluminum. Iron and B6 deficiencies are especially important because they are widespread, but they are also preventable with supplementation. Thus, heme deficiency or dysregulation may be an important and preventable component of the neurodegenerative process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Mitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Good, P. F., Perl, D. P., Bierer, L. M., & Schmeidler, J. (1992) · Annals of Neurology · doi:10.1002/ana.410310310 · Cited by 476
Yan, S. D., Yan, S. F., Chen, X., Fu, J., Chen, M., Kuppusamy, P., Smith, M. A., Perry, G., Godman, G. C., Nawroth, P., et al. (1995) · Nature Medicine · doi:10.1038/nm0795-693 · Cited by 406
Dietary Intake, Dietary Patterns, and Changes With Age: An Epidemiological Perspective
Wakimoto, P., & Block, G. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.suppl_2.65 · Cited by 391
Tamura, T., Goldenberg, R. L., Hou, J., Johnston, K. E., Cliver, S. P., Ramey, S. L., & Nelson, K. G. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.120688 · Cited by 360
Research works printed but not linked: 53
- 10.1212/WNL.44.6.1090 · DOI · Paper page
- Albers D. S. & Beal, M. F. (2000) J. Neural Transm. Suppl.59,133-154.10961426
- 10.1016/S0166-2236(00)01584-8 · DOI · Paper page
- 10.1523/JNEUROSCI.21-13-04923.2001 · DOI · Paper page
- 10.1089/15230860050192198 · DOI · Paper page
- 10.1001/archpsyc.57.1.47 · DOI · Paper page
- 10.1016/0047-6374(83)90029-5 · DOI
- 10.1006/abbi.2001.2671 · DOI
- 10.1074/jbc.M108362200 · DOI · Paper page
- 10.1002/j.1460-2075.1995.tb07005.x · DOI · Paper page
- 10.1093/emboj/20.11.2835 · DOI · Paper page
- 10.1074/jbc.M100103200 · DOI · Paper page
- 10.1038/274372a0 · DOI
- 10.1016/S0048-9697(01)00964-0 · DOI
- 10.3109/03602539308993973 · DOI · Paper page
- 10.1046/j.1432-1327.2000.01519.x · DOI · Paper page
- 10.1042/bj3100533 · DOI · Paper page
- 10.1542/peds.105.4.e51 · DOI · Paper page
- 10.1073/pnas.261708798 · DOI · Paper page
- 10.1016/S0149-7634(01)00015-X · DOI
- 10.1203/00006450-200008000-00009 · DOI · Paper page
- Freedman M. L. (1987) Blood Cells13,227-235.3311219
- 10.1016/S0361-9230(01)00426-9 · DOI
- 10.1007/BF00224769 · DOI
- Gamble J. T., Dailey, H. A. & Marks, G. S. (2000) Drug Metab. Dispos.28,373-375.10725301
- 10.1016/0304-4165(86)90058-9 · DOI
- 10.1016/S0300-483X(97)00164-9 · DOI
- 10.1007/BF02803873 · DOI
- LoPresti P., Poluha, W., Poluha, D. K., Drinkwater, E. & Ross, A. H. (1992) Cell Growth Differ.3,627-635.1419912
- 10.1111/j.1749-6632.1982.tb43411.x · doi:10.1111/j.1749-6632.1982.tb43411.x
- 10.1385/JMN:17:2:205 · DOI · Paper page
- 10.1016/S0361-9230(01)00455-5 · DOI · Paper page
- 10.1074/jbc.M104059200 · DOI · Paper page
- 10.1523/JNEUROSCI.15-03-02157.1995 · DOI · Paper page
- 10.1074/jbc.M100792200 · DOI · Paper page
- 10.1074/jbc.275.12.8929 · DOI · Paper page
- 10.1074/jbc.M105410200 · DOI · Paper page
- 10.1021/bi001048s · DOI · Paper page
- 10.1016/S0891-5849(02)00806-7 · DOI
- 10.1016/S0531-5565(00)00112-1 · DOI
- 10.1093/jn/130.5.1447S · DOI · Paper page
- 10.1016/S0022-510X(01)00672-4 · DOI · Paper page
- Potocnik F. C., van Rensburg, S. J., Park, C., Taljaard, J. J. & Emsley, R. A. (1997) S. Afr. Med. J.87,1116-1119.9358828
- 10.1016/S1567-7249(01)00004-6 · DOI
- 10.1007/s000180050355 · DOI
- 10.1074/jbc.273.20.12555 · DOI · Paper page
- 10.1016/0167-4889(84)90170-8 · DOI
- 10.1016/S0303-7207(01)00536-6 · DOI
- 10.1016/S0896-6273(00)00125-2 · DOI · Paper page
- 10.1016/S0006-8993(02)02981-5 · DOI
- 10.1089/ars.2000.2.1-137 · DOI
- 10.1073/pnas.251466698 · DOI · Paper page
- Smith M. A., Kutty, R. K., Richey, P. L., Yan, S. D., Stern, D., Chader, G. J., Wiggert, B., Petersen, R. B. & Perry, G. (1994) Am. J. Pathol.145,42-47.8030754
Cited by
Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis
Rossignol, D. A., & Frye, R. E. (2012) · Molecular Psychiatry · doi:10.1038/mp.2010.136 · Cited by 907
McCann, J. C., & Ames, B. N. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.4.931 · Cited by 501
Self-citationKoskenkorva-Frank, T. S., Weiss, G., Koppenol, W. H., & Burckhardt, S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.09.001 · Cited by 406
Wang, X., Su, B., Fujioka, H., & Zhu, X. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.071208 · Cited by 341
Heme is involved in microRNA processing
Faller, M., Matsunaga, M., Yin, S., Loo, J. A., & Guo, F. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1182 · Cited by 295
Poon, H. F., Calabrese, V., Scapagnini, G., & Butterfield, D. A. (2004) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2004.02.005 · Cited by 291
Atamna, H., & Boyle, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600134103 · Cited by 290
Self-citationTsiftsoglou, A. S., Tsamadou, A. I., & Papadopoulou, L. C. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.017 · Cited by 281
Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer’s disease
Atamna, H., & Frey, W. H. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.06.001 · Cited by 278
Self-citationNovel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy.
Ishizuka, M., Abe, F., Sano, Y., Takahashi, K., Inoue, K., Nakajima, M., Kohda, T., Komatsu, N., Ogura, S.-I., & Tanaka, T. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2010.11.029 · Cited by 255
Zinc deficiency induces oxidative DNA damage and increases p53 expression in human lung fibroblasts
Ho, E., Courtemanche, C., & Ames, B. N. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.8.2543 · Cited by 252
A role for heme in Alzheimer's disease: Heme binds amyloid β and has altered metabolism
Atamna, H., & Frey, W. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404349101 · Cited by 252
Self-citationThe Heme-Bach1 Pathway in the Regulation of Oxidative Stress Response and Erythroid Differentiation
Igarashi, K., & Sun, J. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.107 · Cited by 246
Moreira, P. I., Harris, P. L. R., Zhu, X., Santos, M. S., Oliveira, C. R., Smith, M. A., & Perry, G. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-12210 · Cited by 196
“The same group reported that heme deficiency in brain cells decreases mitochondrial complex IV activity, activates nitric oxide synthase, alters amyloid-β protein precursor and corrupts iron and zinc homeostasis [5].”
BackgroundShi, Y., Ghosh, M., Kovtunovych, G., Crooks, D. R., & Rouault, T. A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.11.002 · Cited by 194
Systemic messenger RNA as an etiological treatment for acute intermittent porphyria
Jiang, L., Berraondo, P., Jericó, D., Guey, L. T., Sampedro, A., Frassetto, A., Benenato, K. E., Burke, K., Santamaría, E., Alegre, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0199-z · Cited by 181
Goldani, A. A. S., Downs, S. R., Widjaja, F., Lawton, B., & Hendren, R. L. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00100 · Cited by 180
“Mitochondrial dysfunction can be a downstream consequence of many proposed factors including dysreactive immunity and altered calcium (Ca2+) signaling (80), increased nitric oxide and peroxynitrite (68), propionyl CoA (81), malnutrition (82), vitamin B6 or iron deficiencies (83), toxic metals (83), elevated nitric aci…”
BackgroundIron deficiency accelerates Helicobacter pylori–induced carcinogenesis in rodents and humans
Noto, J. M., Gaddy, J. A., Lee, J. Y., Piazuelo, M. B., Friedman, D. B., Colvin, D. C., Romero-Gallo, J., Suarez, G., Loh, J., Slaughter, J. C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64373 · Cited by 178
“Heme iron deficiency and consequent imbalances in iron-containing mitochondrial enzymes can induce DNA damage, oxidative stress, and mitochondrial decay (32).”
Impaired iron status in aging research
Xu, J., Jia, Z., Knutson, M. D., & Leeuwenburgh, C. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13022368 · Cited by 103
“This finding was further confirmed by studies with emphasis on heme deficiency in both neurodegenerative disorders [59–62] and normal aging [19].”
ResultIron Accumulation during Cellular Senescence
KILLILEA, D. W., WONG, S. L., CAHAYA, H. S., ATAMNA, H., & AMES, B. N. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1297.063 · Cited by 97
Self-citationIron Accumulation During Cellular Senescence in Human Fibroblasts In Vitro
Killilea, D. W., Atamna, H., Liao, C., & Ames, B. N. (2003) · Antioxidants & Redox Signaling · doi:10.1089/152308603770310158 · Cited by 92
Self-citationIron and genome stability: an update
Prá, D., Franke, S. I. R., Henriques, J. A. P., & Fenech, M. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2012.02.001 · Cited by 91
Prevention of mutation, Cancer, and other Age-Associated diseases by optimizing micronutrient intake
Ames, B. N. (2010) · Journal of Nucleic Acids · doi:10.4061/2010/725071 · Cited by 51
Self-citationMechanism of Hypochlorous Acid-Mediated Heme Destruction and Free Iron Release
Maitra, D., Byun, J., Andreana, P. R., Abdulhamid, I., Saed, G. M., Diamond, M. P., Pennathur, S., & Abu-Soud, H. M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.040 · Cited by 51
“Heme deficiency mediated by the acceleration in heme destruction and consequent dysregulation of the cellular heme homeostasis may lead to pathological conditions such as Alzheimer disease and aging [8].”
Metadata
- Authors
- Atamna, H., Killilea, D. W., Killilea, A. N., & Ames, B. N.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-11-04
- Volume
- 99
- Issue
- 23
- Pages
- 14807-14812
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1978972221
- Cited by
- 228
- References
- 8
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.